Latest filing published 14 Oct 2026 for Nurix Therapeutics, Inc., €37k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +101.0%Entry US$15.33 · Close at T+365 US$30.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Julia P. Gregory: trading record in brief
Julia P. Gregory, listed as senior executive, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Biohaven Ltd., Biohaven Pharmaceutical Holding Co Ltd. and Nurix Therapeutics, Inc. Over a trading history stretching from 30 December 2005 to 14 October 2026, the count stands at 19 filings.
Both buying and selling appear: 2 purchases worth €149k, against 6 sales worth €2.9M. On balance, insiders were net sellers of €2.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 9 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 14 October 2026: an option exercise of €37k, in Nurix Therapeutics, Inc. The clock since the last published purchase (26 October 2022) now reads 1,474 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julia P. Gregory
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,583 shares@ US$1.860.0018% mcap7.1% of flowCommon StockSEC:0001226675-26-000006:0
- 22,583 shares@ US$23.40380.023% mcap89.7% of flowCommon StockSEC:0001226675-26-000006:1
- 10,750 shares@ US$1.86100.0% of flowCommon StockSEC:0001226675-25-000004:0
- 9,523 shares@ US$10.5083.2% of flowCommon SharesSEC:0001562180-22-007336:0Canonical exit: 23 Jan 2023 (T+90)
- 5,998 shares@ US$3.567.7% of flowCommon SharesSEC:0001562180-22-007079:1
- 9,000 shares@ US$2.337.5% of flowCommon SharesSEC:0001562180-22-007079:2
- 9,000 shares@ US$3.069.9% of flowCommon SharesSEC:0001562180-22-007079:3
- 11,975 shares@ US$7.5032.3% of flowCommon SharesSEC:0001562180-22-007079:4
- 4,119 shares@ US$4.8416.8% of flowCommon SharesSEC:0001562180-22-007079:0
- 12,000 shares@ US$125.0042.4% of flowCommon SharesSEC:0001562180-21-007867:1
- 12,000 shares@ US$23.63100.0% of flowCommon SharesSEC:0001562180-21-007867:0
- 12,000 shares@ US$23.6314.1% of flowCommon SharesSEC:0001689813-19-000095:0
- 12,000 shares@ US$54.7532.8% of flowCommon SharesSEC:0001689813-19-000095:1
- 12,000 shares@ US$23.6313.8% of flowCommon SharesSEC:0001209191-19-012998:0
- 12,000 shares@ US$43.5625.4% of flowCommon SharesSEC:0001209191-19-012998:1
- 11,778 shares@ US$4.61Common Stock, par value $0.0001 per shareSEC:0001209191-15-021924:0Canonical exit: 31 May 2015 (T+90)
- 29,946 shares@ US$4.00Common Stock, par value $0.0001 per shareSEC:0001209191-14-062443:0
- 3,800 shares@ US$3.70Common StockSEC:0001062822-06-000003:0
- 7,200 shares@ US$3.80Common StockSEC:0001062822-06-000003:1
19 of 19 declarations
